TiE Catalyst presents “Innovations & Implications of Early Breast Cancer Detection�

TiE Catalyst presents “Innovations & Implications of Early Breast Cancer Detection”

in partnership with BayBio, the BayBio Institute,

Every 2 minutes, an American woman in the USA is diagnosed with breast cancer.  Most women aren’t aware of a significant risk factor that women with dense breast tissue have, a 4-6x higher risk of breast cancer. Asian and younger women are more prone to have dense breast tissue. The current gold standard of mammography is not optimal to detect cancer in dense breast tissues.
 
Our panel of distinguished thought leaders will discuss:
 
-    Recent advances in early breast cancer detection
-    Breast density as an independent cancer risk factor
-    Technological advancements for screening women with dense breast tissue
-    Legislative issues impacting both women with dense breast tissue and their physicians

Please join us for a networking breakfast reception followed by a panel discussion
 
moderated by:
 
Nandini Tandon, Ph.D.,
Managing Director, Lumira Capital
Chair, TiE Catalyst & Trustee, TiE Global Board
 
Panel experts include:
 
Rachel Brem, MD
Director of Breast Imaging and Intervention and Vice Chair of the Department of Radiology,
at The George Washington University Medical Center, Washington, D.C.
 
Marc Inciardi, MD
Radiologist, University of Kansas Medical Center, Kansas City, KS
 
Jessie Jacob, MD
Director of Breast Imaging, El Camino Hospital, Mountain View, CA
 
 
Wednesday, November 2, 2011

7:30 a.m.
Registration, Breakfast and Networking

8:00 - 9:15 a.m.     
Panel Discussion
 
140 Scott Drive, Menlo Park, CA 94025
At the offices of Latham & Watkins LLP
 
SPACE IS LIMITED
Kindly RSVP in advance to Kristen Glaub at (650) 463-2672 or
Kristen.Glaub@lw.com by Thursday, October 27th

Location

140 Scott Drive, Menlo Park, CA 94025 At the offices of Latham & Watkins LLP

Contact Information

Kristen Glaub at (650) 463-2672 or Kristen.Glaub@lw.com